XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurement (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]  
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents information about our financial assets and liabilities that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation:

 

 

 

September 30, 2021

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

69,644

 

 

$

69,644

 

 

$

 

 

$

 

Short-term marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury notes

 

 

60,555

 

 

 

 

 

 

60,555

 

 

 

 

Commercial paper

 

 

184,277

 

 

 

 

 

 

184,277

 

 

 

 

Corporate debt securities

 

 

134,351

 

 

 

 

 

 

134,351

 

 

 

 

Supranational debt securities

 

 

40,081

 

 

 

 

 

 

40,081

 

 

 

 

Total short-term marketable securities

 

 

419,264

 

 

 

 

 

 

419,264

 

 

 

 

Investment in equity securities

 

 

17,707

 

 

 

17,707

 

 

 

 

 

 

 

LianBio Warrants

 

 

2,878

 

 

 

 

 

 

 

 

 

2,878

 

Total financial assets

 

$

509,493

 

 

$

87,351

 

 

$

419,264

 

 

$

2,878

 

Liability

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative

 

$

1,413

 

 

$

 

 

$

 

 

$

1,413

 

 

 

 

December 31, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

266,437

 

 

$

266,437

 

 

$

 

 

$

 

Short-term marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasury bills

 

 

14,999

 

 

 

 

 

 

14,999

 

 

 

 

U.S. treasury notes

 

 

45,391

 

 

 

 

 

 

45,391

 

 

 

 

Commercial paper

 

 

144,851

 

 

 

 

 

 

144,851

 

 

 

 

Corporate debt securities

 

 

45,770

 

 

 

 

 

 

45,770

 

 

 

 

Total short-term marketable securities

 

 

251,011

 

 

 

 

 

 

251,011

 

 

 

 

LianBio Warrants

 

 

3,338

 

 

 

 

 

 

 

 

 

3,338

 

Total financial assets

 

$

520,786

 

 

$

266,437

 

 

$

251,011

 

 

$

3,338

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

LEO call option liability

 

$

5,550

 

 

$

 

 

$

 

 

 

5,550

 

Embedded derivative

 

 

1,340

 

 

 

 

 

 

 

 

 

1,340

 

Total financial liabilities

 

$

6,890

 

 

$

 

 

$

 

 

$

6,890

 

LEO Call Option  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]  
Summary of Change in Estimated Fair Value of Liability Recorded in Other Income (Expense), Net

On March 30, 2021, LEO provided a notice of termination of the LEO call option effective April 15, 2021. As a result and based on the facts and circumstances that existed as of March 31, 2021, we evaluated that the likelihood of LEO exercising said option was remote and we remeasured the LEO call option liability to zero as of March 31, 2021. The following table sets forth a summary of the change in the estimated fair value of the LEO call option recorded in “Other income (expense), net”:

 

 

 

Total

 

 

 

(in thousands)

 

Balance as of December 31, 2020

 

$

5,550

 

Change in fair value upon notice of termination
  of the LEO call option

 

 

(5,550

)

Balance as of March 31, 2021

 

$

 

Schedule of Estimated Fair Value of Liability

Historically, we estimated the fair value of the LEO call option by estimating the fair value of various clinical, regulatory, and sales milestones based on the estimated risk and probability of achievement of each milestone, and allocated the value using a Black-Scholes option pricing model with the following assumptions as of December 31, 2020:

 

 

 

December 31,

 

 

2020

Probability of milestone achievement

 

12.0%-84.0%

Discount rate

 

0.1%-14.3%

Expected term (in years)

 

1.25-6.25

Expected volatility

 

80.0%-95.0%

Risk-free interest rate

 

1.16%-1.53%

Dividend yield

 

 —